InMed Pharmaceuticals Inc. (NASDAQ: INM) Stock Information | RedChip

InMed Pharmaceuticals Inc. (NASDAQ: INM) Listen to this Section


$0.15
+0.0042 ( +2.98% ) 89.9K

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

Market Data


Open


$0.15

Previous close


$0.14

Volume


89.9K

Market cap


$1.33M

Day range


$0.14 - $0.15

52 week range


$0.12 - $2.08

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Dec 26, 2023
4 Insider transactions 1 Dec 26, 2023
4 Insider transactions 1 Dec 26, 2023
4 Insider transactions 1 Dec 26, 2023
4 Insider transactions 1 Dec 26, 2023
10-k/a Quarterly Reports 18 Dec 21, 2023
8-k 8K-related 14 Dec 20, 2023
4 Insider transactions 1 Dec 06, 2023
8-k 8K-related 14 Nov 29, 2023
8-k 8K-related 14 Nov 14, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.